Development of MDM2‐Targeting PROTAC for Advancing Bone Regeneration
Abstract Proteolysis‐targeting chimeras (PROTACs) degrade target proteins through the ubiquitin‐proteasome system. To date, PROTACs are primarily used to treat various diseases; however, they have not been applied in regenerative therapy. Herein, this work introduces MDM2‐targeting PROTACs customize...
Saved in:
| Main Authors: | Sol Jeong, Jae‐Kook Cha, Wasim Ahmed, Jaewan Kim, Minsup Kim, Kyung Tae Hong, Wonji Choi, Sunjoo Choi, Tae Hyeon Yoo, Hyun‑Ju An, Seung Chan An, Jaemin Lee, Jimin Choi, Sun‐Young Kim, Jun‐Seok Lee, Soonchul Lee, Junwon Choi, Jin Man Kim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-05-01
|
| Series: | Advanced Science |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/advs.202415626 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mdm2 targeting via PROteolysis TArgeting Chimeras (PROTAC) is efficient in p53 wildtype, p53-mutated, and abemaciclib-resistant estrogen receptor-positive cell lines and superior to mdm2 inhibition
by: Alina Goerg, et al.
Published: (2025-06-01) -
Strategies for p53 Activation and Targeted Inhibitors of the p53-Mdm2/MdmX Interaction
by: Ye Huang, et al.
Published: (2025-04-01) -
Mechanistic Role of the Mdm2/MdmX Lid Domain in Regulating Their Interactions with p53
by: Qiuyin Wei, et al.
Published: (2025-04-01) -
PROTAC Technology as a New Tool for Modern Pharmacotherapy
by: Natalia Kubryń, et al.
Published: (2025-05-01) -
Exploring the heterodimer MDM2/MDM4 interaction region uncovers high-affinity peptides for therapeutic p53-reactivation
by: Marika Attili, et al.
Published: (2025-05-01)